（原标题：股价创历史新高，藏格矿业上半年业绩大幅预增，紫金矿业赋能或助力进阶全球锂业龙头） 申万一级有色金属行业年内表现最亮眼，累计涨幅超20%，高居第一。21只个股年内股价创出历史新高，7股则是在7月份创出历史新高。这7股当 中，藏格矿业于近期发布了半年报预增公告，业绩重回历史同期高位。 更为重要的是，今年5月藏格矿业发布公告称，控股股东由藏格创投变更为紫金国际（紫金矿业子公司）。紫金矿业入主后，藏格矿业实控人变更 为上杭县财政局，公司国企属性强化了其资源获取能力。同时，紫金矿业承诺优先将锂钾业务交由藏格矿业运营。分析人士指出，未来公司有望 成为紫金系核心锂平台，解决同业竞争问题，从而进阶全球锂业龙头。 上半年业绩大幅预增，巨龙铜业投资收益成关键支撑 藏格矿业股价创出历史新高，其背后有着强大的基本面支撑。公司近期发布的2025年上半年业绩预告显示，预计实现归母净利润17.5亿—19.0亿 元，同比增幅34.93%—46.49%，扣非净利润增速更高达38.54%—50.29%，公司上半年业绩处于历史相对高位。 公司业绩增长的主要推动力来自参股公司西藏巨龙铜业有限公司。报告期内，巨龙铜业净利润实现增长，藏格矿业 ...

证券代码：002748 证券简称：世龙实业 公告编号：2025-028 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、本期业绩预计情况 1、业绩预告期间：2025年1月1日至2025年6月30日 2、预计的经营业绩：□亏损 □扭亏为盈 R同向上升 □同向下降 二、与会计师事务所沟通情况 本次业绩预告数据是公司财务部门初步测算的结果，未经审计机构审计。 登录新浪财经APP 搜索【信披】查看更多考评等级 报告期内，除烧碱销售价格同比上涨外，公司其他主要产品AC发泡剂、氯化亚砜销售价格较上年同期 略有下降，双氧水产品销售价格同比出现较大幅度地下滑。在此情况下，公司持续加大生产负荷与国内 外市场营销力度，公司及子公司-江西世龙新材料有限公司的主要产品AC发泡剂、氯化亚砜、烧碱、双 氧水及丙酸等产销量均实现同比增长，公司整体营业收入较上年同期有所上升。 与此同时，公司煤、盐、尿素等大宗原材料的采购成本较上年同期均有显著下降，公司产品综合毛利率 同比上升，公司经营业绩亦随之实现大幅增长。 四、风险提示 本次业绩预告数据是公司财务部门初步测算的结果，未经审计机构审计， ...

最新一期业绩显示，2025年一季报，公司实现营业收入12.13亿元，同比91.47%；净利润3.84亿元，同 比373.53%，销售毛利率54.12%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13亚钾国际24.0931.772.50301.98亿行业平均 25.2226.542.46161.93亿行业中值22.7925.421.7380.90亿1云天化7.987.731.74412.18亿2史丹利 11.6712.371.43102.17亿3新洋丰11.7513.271.58174.53亿4云图控股14.4115.131.36121.74亿5兴发集团 15.8915.181.11243.16亿6司尔特16.8014.690.8645.75亿7盐湖股份19.0019.862.46926.03亿8东方铁塔 19.5220.831.29117.56亿9芭田股份19.8825.613.09104.80亿10四川美丰21.4414.500.9439.40亿11华昌化工 22.4613.241.2069.05亿12湖北宜化23.1219.481.71127.09亿 来源：金融界 从行业市盈率排名来看，公司 ...

基础化工行业 超配（维持） 基础化工行业双周报（2025/6/27-2025/7/10） 行 业 中央财经委员会第六次会议强调依法依规治理企业低价无序竞争 本报告的风险等级为中风险。 本报告的信息均来自已公开信息，关于信息的准确性与完整性，建议投资者谨慎判断，据此入市，风险自担。 请务必阅读末页声明。 投资要点： 2025 年 7 月 11 日 行情回顾：截至2025年7月10日，中信基础化工行业近两周上涨2.57%， 跑赢沪深300指数0.95个百分点，在中信30个行业中排名第14。 周 报 分析师：卢立亭 SAC 执业证书编号： S0340518040001 电话：0769-22177163 邮箱：luliting@dgzq.com.cn 化工产品涨跌幅：重点监控的化工产品中，最近一周价格涨幅前五的产 品是维生素B1（+12.82%）、脂肪醇（+8.16%）、二氯丙烷-白料（+8.11%）、 维生素D3（+7.14%）、百草枯（+6.56%），价格跌幅前五的产品是液氯 （-48.51%）、盐酸（-8.29%）、丁基橡胶（-7.79%）、苯胺（-6.05%）、 氯化钙（-5.06%）。 基础化工行业周观点： ...

8 服 热 导发 E 户网 站 100 - 100 la pa www.itf.com.cn 400-8888-598 ts No 180 14/1 | | | | 投资咨询业务资格:证监许可【2012】 31号 | | ITC国贸期货 | | --- | --- | --- | --- | --- | --- | | | | | 国贸期货研究院 | 蜈致 据 日报 期货从业号:F305427 | | | | | | 能源化工研究中心 陈一凡 | 投资咨询证号:Z0015946 | 2025/07/11 | | 指标 | | 2025/07/09 | 2025/07/10 | 涨跌值 | 行情评述 | | | 晋城大烟煤 | 900. 00 | 900. 00 | 0. 00 | | | | 内蒙动力煤 | 630. 00 | 630. 00 | 0.00 | | | 77 74 | 川渝液化气 | 4350.00 | 4350. 00 | 0. 00 | | | | 国际大然气 | 11.64 | 11.72 | 0. 09 | | | | 太仓 | 2375.00 | 2380.00 | 5.00 | 昨 ...

Core Viewpoint - Tian Tie Technology (300587.SZ) has set ambitious targets for 2025 despite facing challenges from the temporary shutdown of its subsidiary Changjili due to a steam supply disruption caused by a lightning strike [1][2][4] Group 1: Company Performance and Targets - Tian Tie Technology aims for a revenue target of no less than 2.3 billion yuan and a net profit of no less than 580 million yuan for 2025, representing a revenue growth of 7.68% and a net profit increase of approximately 370% [1][9] - In Q1 2025, the company reported a revenue of 358 million yuan, a year-on-year decline of 39.92%, and a net profit of 10.26 million yuan, down 45.60% year-on-year [1][10] - The company achieved a revenue of 2.136 billion yuan in 2024, a year-on-year increase of 41.69%, and a net profit of 15.20 million yuan, up 102.33% [6][7] Group 2: Subsidiary Challenges - Changjili, a wholly-owned subsidiary, has been facing continuous losses with a debt ratio of 89.34% as of Q1 2025, indicating increasing financial strain [3][4] - The subsidiary's revenue for 2024 and Q1 2025 was 942 million yuan and 121 million yuan, respectively, with net losses of 60.53 million yuan and 17.44 million yuan [3][4] - The expected resumption of operations at Changjili has been delayed by approximately 10 days, with a new target date set for July 20, 2025 [1][2][3] Group 3: Market and Operational Impact - The steam supply disruption has temporarily halted operations at Changjili, but the company believes this will not significantly impact overall operations due to the ongoing production at its other subsidiary, Anhui Tian Tie [5][6] - The company is closely monitoring the repair and adjustment progress of the steam supplier, which is crucial for Changjili's operations [4][5] - The overall market environment for lithium products is expected to remain challenging, with prices continuing to decline, although at a slower rate than in 2023 [6][7]

Group 1 - The company, Qingdao Oriental Tower Co., Ltd., expects a significant increase in net profit for the first half of 2025, projecting a profit of 451 million to 495 million yuan, representing a year-on-year growth of 62.04% to 78.35% [2] - The basic earnings per share are estimated to be between 0.3625 yuan and 0.3978 yuan, compared to 0.2213 yuan in the same period last year [2] - The increase in profitability is attributed to the rise in market prices for potassium chloride products, which is expected to boost the company's potassium fertilizer business [2] Group 2 - The performance forecast period is from January 1, 2025, to June 30, 2025, and the financial data has not yet been audited by the accounting firm [2] - The company has communicated with the auditing firm regarding the performance forecast, and there are no discrepancies between the two parties [2]

Major Events - QianShi International (00381) subsidiary FuLao Investment signed a memorandum of understanding with Yanji Municipal Government for potential cooperation in digital economy-related businesses in Hong Kong [1] - Stone Pharmaceutical Group (02005) obtained production registration approval for potassium chloride and sodium chloride injection (500ml and 250ml) [1] - Basilea Pharmaceutica (02616) received approval from the National Medical Products Administration for the domestic production registration application of Prujita® (Pralsetinib capsules) [1] - United BioPharma (03933) received FDA approval for new drug clinical trials for UBT37034 injection [1] - China National Pharmaceutical Group (01177) had the application for the new indication of Kumosil capsules for first-line treatment of breast cancer accepted [1] - Oceanwide Holdings (08476) applied to the Stock Exchange for a transfer listing to the main board [1] Financial Data - Kaison Holdings (00102) reported a loss attributable to shareholders of approximately HKD 740 million for 2023, a shift from profit to loss year-on-year [1] - JiaoGe Friends Holdings (01450) achieved a cumulative GMV of approximately CNY 6.98 billion in the first half of the year, a year-on-year increase of approximately 17.11% [1] - Sunny Optical Technology (02382) reported a smartphone lens shipment of approximately 95.056 million units in June, a month-on-month decrease of 3.1% and a year-on-year decrease of 12.7% [1] - Fast Retailing (06288) announced a profit attributable to the parent company of JPY 339.099 billion for the first three quarters, a year-on-year increase of 8.4% [1] - Jianye Real Estate (00832) reported a total property contract sales of CNY 4.44 billion in the first half of the year, a year-on-year decrease of 1.2% [1] - China Lilang (01234) reported a mid-to-high single-digit year-on-year growth in retail sales of "LILANZ" products in the first half of the year [1]

证券代码：300801 证券简称：泰和科技 山东泰和科技股份有限公司 2025 年 7 月 9 日投资者关系活动记录表 编号：2025-004 投资者关 系活动类 别 特定对象调研 分析师会议 媒体采访 业绩说明会 新闻发布会 路演活动 现场参观 其他 参与单位 名称及人 员姓名 西部证券：孙维容 时间 2025 年 7 月 9 日 10:00-12:00 地点 山东省枣庄市市中区十里泉东路 1 号泰和科技 会议室 上市公司 接待人员 姓名 1、董事长、总工程师：程终发 2、董事、总经理、董事会秘书：姚 娅 投资者关 系活动主 要内容介 绍 本次调研不涉及应披露的重大信息。 调研问题回复： 1、公司的连续化生产是指？它的优势是什么？ 回复：连续化生产是指通过连续化、成套化、自动化、规模化 的精细化工产品生产设备及工艺，实现连续进料、连续出料，并非 24 小时不停工生产。间歇式生产是指间歇性投料，生产完毕后，将 釜内物料放出，再投下一釜进行生产。相比间歇式生产，连续化生 产的优势是安全、投资小、产品质量稳定、用人少。目前泰和科技 的生产车间已实现连续化、自动化、无人化生产。 2、公司自产上游原料三氯化磷，产能规 ...

Investment Rating - The report rates the industry as "Positive" [6] Core Insights - Potassium is one of the three essential nutrients for crop growth, often referred to as "the grain of food" [2] - The global potassium fertilizer market is projected to reach USD 28.12 billion in 2024, with a compound annual growth rate (CAGR) of 3.9% expected until 2033 [27] - The supply of potassium is dominated by a few major players, leading to a clear oligopoly in the industry [2][44] Industry Overview - Potassium is essential for crop growth, with a market size exceeding USD 100 billion [15] - The potassium resource is divided into solid potassium ores and potassium brine, with solid potassium ores being the majority [28] - Global potassium resources are unevenly distributed, with China holding only 4% of the world's reserves, leading to significant reliance on imports [2][53] Demand Analysis - Global potassium fertilizer demand is expected to grow steadily due to population increases, with an average annual growth rate of 2.67% projected from 2024 to 2030 [3] - Key regions driving demand include China, Southeast Asia, and Brazil, with specific agricultural practices increasing potassium usage [3][18] - By 2030, global potassium fertilizer demand is anticipated to reach 85.2 million tons [3] Supply Analysis - Capital expenditures for greenfield potassium projects are substantial, with development cycles typically ranging from 7 to 10 years [4] - Major projects, such as BHP's Jansen project, are expected to significantly increase global potassium production capacity [4][20] - If current projects are completed on schedule, global potassium production could reach 90.9 million tons by 2030, with a CAGR of 2.35% from 2024 to 2030 [4] Price Trends - Short-term price trends for potassium fertilizers are expected to be strong, influenced by supply constraints and high demand in key markets [5] - The price of potassium fertilizers is projected to face upward pressure until 2026, after which it may stabilize as new projects come online [5][26] - The long-term price will be supported by marginal costs, despite potential oversupply in the future [5]